DrugPatentWatch Database Preview
Aminolevulinic acid hydrochloride - Generic Drug Details
What are the generic drug sources for aminolevulinic acid hydrochloride and what is the scope of aminolevulinic acid hydrochloride patent protection?
Aminolevulinic acid hydrochloride
is the generic ingredient in three branded drugs marketed by Nxdc, Biofrontera, and Dusa, and is included in three NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for aminolevulinic acid hydrochloride. Three suppliers are listed for this compound.
Summary for aminolevulinic acid hydrochloride
| US Patents: | 5 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 6 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 100 |
| Clinical Trials: | 67 |
| Patent Applications: | 223 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for aminolevulinic acid hydrochloride |
| DailyMed Link: | aminolevulinic acid hydrochloride at DailyMed |
Pharmacology for aminolevulinic acid hydrochloride
| Ingredient-type | Porphyrinogens |
| Drug Class | Porphyrin Precursor |
Medical Subject Heading (MeSH) Categories for aminolevulinic acid hydrochloride
Synonyms for aminolevulinic acid hydrochloride
| .delta.-Aminolevulinic acid hydrochloride |
| 0C1E43DB-1221-4963-BFA4-18D3170000A4 |
| 4-carboxy-2-oxobutan-1-aminium chloride |
| 451A092 |
| 5 ALA HCL |
| 5-amino levulinic acid hydrochloride |
| 5-Amino-3-oxopentanoic acid (hydrochloride) |
| 5-amino-4-keto-valeric acid |
| 5-Amino-4-ketovaleric acid hydrochloride |
| 5-AMINO-4-OXOPENTANOIC ACID HCL |
| 5-Amino-4-oxopentanoic acid hydrochloride |
| 5-amino-4-oxopentanoic acid hydrochloride;5-Amino-4-oxopentanoic acid |
| 5-amino-4-oxopentanoic acid, chloride |
| 5-Amino-4-oxovaleric acid hydrochloride |
| 5-amino-levulinic acid hydrochloride |
| 5-Aminolaevulinic acid hydrochloride |
| 5-Aminolevulinate hydrochloride |
| 5-Aminolevulinic acid (hydrochloride) |
| 5-Aminolevulinic acid HCl |
| 5-Aminolevulinic acid hydrochloride |
| 5-aminolevulinic acid hydrochloride salt |
| 5-Aminolevulinic acid hydrochloride, >=97.0% (AT) |
| 5-Aminolevulinic acid hydrochloride, >=98% |
| 5-Aminolevulinic acid hydrochloride, BioReagent, suitable for cell culture, powder, >=98% |
| 5-Aminolevulinic acid hydrochloride, GMP |
| 5-Aminolevulinic acid hydrochloride, particle size < 0.25 mm |
| 5-Aminolevulinic Acid, Hydrochloride Salt |
| 5-aminolevulinic acid.HCl |
| 5451-09-2 |
| A-6100 |
| A-6102 |
| A-6103 |
| A0325 |
| AB1005459 |
| AC-4252 |
| AC1L3WYV |
| AC1Q5HEA |
| ACT05562 |
| AK-30504 |
| AKOS015904495 |
| ALA HCl |
| ALA-PDT |
| AlaCare |
| AM20100341 |
| Ameluz |
| Ameluz (TN) |
| Aminolevulinic Acid HCl |
| Aminolevulinic acid hydrochloride (JAN/USAN) |
| Aminolevulinic acid hydrochloride [USAN] |
| Aminolevulinic acid hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| ANW-43114 |
| AT-6127 |
| AX8102341 |
| BC210778 |
| BCP9000174 |
| BR-30504 |
| C-04944 |
| C5H9NO3.HCl |
| CA-291 |
| CAS-5451-09-2 |
| CC-21174 |
| CCG-39079 |
| CHEBI:132969 |
| CHEMBL1200582 |
| CS-2575 |
| CTK1G9933 |
| D02908 |
| D0O4GY |
| DB-005367 |
| delta-Aminolevulinic acid hydrochloride |
| DSSTox_CID_25914 |
| DSSTox_GSID_45914 |
| DSSTox_RID_81222 |
| DTXSID5045914 |
| EINECS 226-679-5 |
| FT-0082845 |
| Gleolan |
| Gliolan |
| GM8475 |
| GS-3020 |
| HMS1922F13 |
| HY-N0305 |
| I14-1649 |
| KB-196689 |
| KB-244625 |
| KS-000001DZ |
| KSC269S3H |
| Levulan |
| Levulan (TN) |
| Levulan Kerastick |
| Levulinic acid, 5-amino-, hydrochloride |
| Levulinic acid, 5-amino-, hydrochloride (8CI) |
| LS-87948 |
| M-2865 |
| MCULE-8125179397 |
| MFCD00012869 |
| MolPort-001-757-321 |
| NCGC00095111-01 |
| NCGC00095111-02 |
| NCGC00095111-03 |
| NCGC00178086-03 |
| NSC 18509 |
| NSC-18509 |
| NSC-758687 |
| NSC18509 |
| NSC758687 |
| OR002139 |
| OR1490 |
| PD-P-506-A |
| Pentanoic acid, 5-amino-4-oxo-, hydrochloride |
| Pentanoic acid, hydrochloride |
| Pentanoicacid, 5-amino-4-oxo-, hydrochloride (1:1) |
| Pharmakon1600-01504184 |
| RL04038 |
| RP23037 |
| RTR-019277 |
| S2553 |
| SBB003880 |
| SC-18502 |
| SC-52394 |
| SCHEMBL192308 |
| SPECTRUM1504184 |
| ST2411714 |
| ST50824911 |
| Tox21_111426 |
| Tox21_111426_1 |
| TPC-I025 |
| TR-019277 |
| UNII-V35KBM8JGR |
| V35KBM8JGR |
| ZLHFONARZHCSET-UHFFFAOYSA-N |
| ZX-AT009947 |
US Patents and Regulatory Information for aminolevulinic acid hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biofrontera | AMELUZ | aminolevulinic acid hydrochloride | GEL;TOPICAL | 208081-001 | May 10, 2016 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Nxdc | GLEOLAN | aminolevulinic acid hydrochloride | FOR SOLUTION;ORAL | 208630-001 | Jun 6, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for aminolevulinic acid hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | ➤ Sign Up | ➤ Sign Up |
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | ➤ Sign Up | ➤ Sign Up |
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | ➤ Sign Up | ➤ Sign Up |
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | ➤ Sign Up | ➤ Sign Up |
| Dusa | LEVULAN | aminolevulinic acid hydrochloride | SOLUTION;TOPICAL | 020965-001 | Dec 3, 1999 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for aminolevulinic acid hydrochloride
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 753997 | ➤ Sign Up |
| Australia | 3858699 | ➤ Sign Up |
| Australia | 1271000 | ➤ Sign Up |
| Spain | 2237102 | ➤ Sign Up |
| Turkey | 200003233 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: